Strong and diffuse immunopositivity or identification of TP53 mutation differentiates IDH mutant astrocytoma from IDH mutant oligodendroglioma (Takami et al., 2015). The gene discussed is IDH2; the disease is astrocytoma (excluding glioblastoma).